-
- Anti Cancer, Leukemia
Ivosenib 250mg (Ivosidenib 250mg)| Treatment Acute Myeloid Leukemia (AML)
- Ivosenib 250mg (Ivosidenib 250mg) is a groundbreaking medication designed to Treatment Acute Myeloid Leukemia (AML), particularly in patients with a specific genetic mutation called IDH1. This targeted therapy offers new hope for patients whose cancer is resistant to conventional treatments, providing a highly specialized approach that can transform the course of this aggressive blood cancer.
- Read more
